Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia

by Phu Ngoc Tran, Xiao-Tang Kong
Published 2017-05-01

Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy

by Steven Du, Daniela Bota, Xiao-Tang Kong
Published 2022-06-01

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

by Maya Hrachova, Emely Nhi T. Nguyen, Beverly D. Fu, Beverly D. Fu, Manisha J. Dandekar, Xiao-Tang Kong, Xiao-Tang Kong, Xiao-Tang Kong, Gilbert Cadena, Gilbert Cadena, Frank P. K. Hsu, Frank P. K. Hsu, John Billimek, Thomas H. Taylor, Daniela A. Bota, Daniela A. Bota, Daniela A. Bota, Daniela A. Bota
Published 2020-05-01

Codon 201Gly Polymorphic Type of the DCC Gene is Related to Disseminated Neuroblastoma

by Xiao-Tang Kong, Seung Hoon Choi, Fumio Bessho, Miyuki Kobayashi, Ryoji Hanada, Keiko Yamamoto, Yasuhide Hayashi
Published 2001-01-01

Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports

by Jason T Pham, Ronald C Kim, Anna Nguyen, Daniela Bota, Xiao-Tang Kong, Sumeet Vadera, Frank Hsu, Jose A Carrillo
Published 2018-04-01

A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolum...

by Daniela A. Bota, Daniela A. Bota, Daniela A. Bota, Thomas H. Taylor, Thomas H. Taylor, Naomi Lomeli, Xiao-Tang Kong, Xiao-Tang Kong, Xiao-Tang Kong, Beverly D. Fu, Beverly D. Fu, Axel H. Schönthal, Samuel Singer, Deborah T. Blumenthal, Frank M. Senecal, Helena Linardou, Evangelos Rokas, Dimitris G. Antoniou, Virgil E. J. C. Schijns, Thomas C. Chen, Thomas C. Chen, Thomas C. Chen, Joseph Elliot, Apostolos Stathopoulos, Apostolos Stathopoulos, Apostolos Stathopoulos, Apostolos Stathopoulos
Published 2022-06-01

Lack of Homozygously Inactivated p73 in Single-Copy MYCN Primary Neuroblastomas and Neuroblastoma Cell Lines

by Xiao-Tang Kong, Virginia A. Valentine, Susan T. Rowe, Marcus B. Valentine, Susan T. Ragsdale, Bart G. Jones, Deborah A. Wilkinson, Garrett M. Brodeur, Susan L. Cohn, A. Thomas Look
Published 1999-04-01

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

by Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert O’Donnell, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor
Published 2020-11-01

331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma

by Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Published 2021-11-01

333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblasto...

by Gabriel Nistor, Robert Dillman, Aleksandra Poole, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Published 2021-11-01

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts

by Daniela A Bota, Jinah Chung, Manisha Dandekar, Jose A Carrillo, Xiao-Tang Kong, Beverly D Fu, Frank PK Hsu, Axel H Schönthal, Florence M Hofman, Thomas C Chen, Raphael Zidovetzki, Chrystel Pretto, Ankie Strik, Virgil EJC Schijns, Apostolos Stathopoulos
Published 2018-07-01

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

by Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Published 2022-12-01

Therapeutic Immunization against Glioblastoma

by Virgil E. J. C. Schijns, Chrystel Pretto, Anna M. Strik, Rianne Gloudemans-Rijkers, Laurent Devillers, Denis Pierre, Jinah Chung, Manisha Dandekar, Jose A. Carrillo, Xiao-Tang Kong, Beverly D. Fu, Frank P. K. Hsu, Florence M. Hofman, Thomas C. Chen, Raphael Zidovetzki, Daniela A. Bota, Apostolos Stathopoulos
Published 2018-08-01

ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BL...

by Bota, Daniela, Taylor, Thomas, Xiao-Tang, Kong, Fu, Beverly, Alsharif, Mohamad, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Published 2019

ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEW...

by Bota, Daniela, Taylor, Thomas, Picconi, David, Duma, Christopher, Aiken, Robert, LaRocca, Renato, Xiao-Tang, Kong, Fu, Beverly, Alsharif, Mohamad, Hsieh, Candace, Nistor, Gabriel, Dillman, Robert
Published 2019